Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/16/2008CA2693256A1 Methods of use of gamma inhibitor compounds for the attenuation of pain
10/16/2008CA2688736A1 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
10/16/2008CA2683862A1 Fusion protein of collagen-binding domain and parathyroid hormone
10/16/2008CA2683643A1 Imaging and therapy of virus-associated tumors
10/16/2008CA2682897A1 Methods of treatment using glycopegylated g-csf
10/16/2008CA2682887A1 Bis-met histones
10/16/2008CA2682623A1 Peptides, antibodies and fragments thereof for the treatment and diagnostic of celiac disease
10/16/2008CA2682507A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo
10/16/2008CA2681746A1 Prophylactic agent for heart failure
10/16/2008CA2681551A1 Prophylactic agent for renal failure
10/16/2008CA2680948A1 Methods of treating or preventing emesis using growth hormone secretagogues
10/16/2008CA2680329A1 Pharmaceutical formulations of ghrh molecules
10/15/2008EP1980618A2 Human DNASE I variants
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1980572A1 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
10/15/2008EP1980571A1 Anti-tumor drug, medicament, composition, and use thereof
10/15/2008EP1980265A1 Therapeutic agent
10/15/2008EP1980264A1 Pharmaceutical composition, food or drink, or feed for intestinal disease
10/15/2008EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
10/15/2008EP1980254A1 Means and methods for counteracting protein aggregation
10/15/2008EP1980240A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/15/2008EP1979374A2 Template-fixed peptidomimetics
10/15/2008EP1978999A2 Isolated mcpip and methods of use
10/15/2008EP1978998A1 Use of parathyroid hormone for treating periodontal disease and for other dental applications
10/15/2008EP1978997A1 Transdermal delivery of pharmaceutical agents
10/15/2008EP1978996A2 Small-volume oral transmucosal dosage forms
10/15/2008EP1978995A1 Method for the treatment and/or prophylaxis of multiple sclerosis, and use of erythropoietin for the manufacture of a medicament for the intermittent treatment and/or intermittent prophylaxis of multiple sclerosis
10/15/2008EP1978994A2 Bmp-7 variant compositions, methods and uses
10/15/2008EP1978993A2 Compositions and methods for diagnosing and treating cancer
10/15/2008EP1978992A2 Inhibitors of cell migration mediated by h-prune-gsk-3 complex and uses in antitumoral therapy
10/15/2008EP1978991A1 Isolated organ perfusion combination therapy of cancer
10/15/2008EP1978990A2 Compositions comprising igbpma and uses thereof
10/15/2008EP1978989A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/15/2008EP1978988A2 Peptide-based regulation of gap junctions
10/15/2008EP1978987A2 Methods and compositions related to improving properties of pharmacological agents targeting nervous system
10/15/2008EP1978986A2 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
10/15/2008EP1978974A1 Methods of treating degenerative disorders with rac 1b inhibitor
10/15/2008EP1978949A2 Combination preparation for improving sperm quality
10/15/2008EP1978932A1 Water stabilized aerosol formulation system and method of making
10/15/2008EP1978802A2 Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
10/15/2008EP1944369A9 Dbait and its standalone uses thereof
10/15/2008EP1940445A4 Stem cell derived factors for treating pathologic conditions
10/15/2008EP1909826B1 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin
10/15/2008EP1669463B1 Casein hydrolyzate, process for producing the same and use thereof
10/15/2008EP1663118A4 Peptide-based conditioners and colorants for hair, skin, and nails
10/15/2008EP1608397B1 S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
10/15/2008EP1480614B1 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
10/15/2008EP1466614B1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
10/15/2008EP1446162B1 Combination motif immune stimulatory oligonucleotides with improved activity
10/15/2008EP1435991B1 Use of aplidine for the treatment of pancreatic cancer
10/15/2008EP1415663B1 Sustained release hgf hydrogel preparations
10/15/2008EP1414421B1 The treatment of lipodystrophy with inhibitors of the renin angiotensin system
10/15/2008EP1406649B9 Use of substances with oxytocin activity against climacteric disorders
10/15/2008EP1351742B1 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
10/15/2008EP1339871B1 Diagnosis and treatment of tumor-suppressor associated disorders
10/15/2008EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/15/2008EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/15/2008EP1272515B1 Immunoregulator
10/15/2008EP1242456B1 Scfv antibodies against disease associated molecules
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
10/15/2008EP1045906B1 Apo-2 ligand
10/15/2008EP0870036B1 Synthetic mammalian alpha-n-acetylglucosaminidase and genetic sequences encoding same
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008CN101287988A Methods and compositions for diagnosis and treatment of influenza
10/15/2008CN101287831A T-cell receptor and nucleic acid encoding the receptor
10/15/2008CN101287827A Amidases, nucleic acids encoding them and methods for making and using them
10/15/2008CN101287826A Compositions and methods for culturing embryos and oocytes
10/15/2008CN101287759A Methods for treating and preventing fibrosis
10/15/2008CN101287755A Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
10/15/2008CN101287753A Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target
10/15/2008CN101287752A Antigenic peptides and their use
10/15/2008CN101287749A Peptides and compounds that bind to a receptor
10/15/2008CN101287747A GDNF derived peptides
10/15/2008CN101287502A Compositions and methods for treating HIV infection with cupredoxin and cytochrame c
10/15/2008CN101287501A Nod1 as an anti-tumor agent
10/15/2008CN101287487A Agents and methods based on the use of the EDA domain of fibronectin
10/15/2008CN101287486A Method of improving learning and memory in mammals
10/15/2008CN101287485A Anti-angiogenic compounds
10/15/2008CN101287484A Binding agents which inhibit myostatin
10/15/2008CN101287483A Pharmaceutical compositions and methods for accelerating wound healing
10/15/2008CN101287477A Composition containing nano grain of silver and application thereof
10/15/2008CN101287449A Preservation of bioactive materials by spray drying
10/15/2008CN101285064A Novel conus P-superfamily toxin sequence, preparation method and uses thereof
10/15/2008CN101285063A Novel conus P-superfamily toxin, sequence and uses thereof
10/15/2008CN101285061A Fungal cell wall synthesis gene
10/15/2008CN101284877A Recombinant target fusion protein of antithrombin activity and anti-platelet aggregation and preparation method
10/15/2008CN101284876A Fusion protein Penharpin, preparation method and use
10/15/2008CN101284874A Peptide-based immunization therapy for treatment of atherosclerosis
10/15/2008CN101284873A Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2008CN101284870A Polypeptides of anti-measles virus and human immunodeficiency virus and use
10/15/2008CN101284869A Antiviral polypeptides and use
10/15/2008CN101284865A New compound and its medicine use
10/15/2008CN101284146A Dry hemostatic compositions and methods for their preparation
10/15/2008CN101284135A Mono-modified polyethyleneglycol-insulin complexes and preparation method thereof
10/15/2008CN101284129A Composition containing lactase and vitamin D
10/15/2008CN101284128A Medicine for relieving or neutralizing the effect of alcohol and resisting intoxication and preparation method thereof
10/15/2008CN101284127A Injection for curing angiomatous
10/15/2008CN101283956A Uses of choline esterase in skin nursing material for treating or improving the skin symptom
10/15/2008CN100425700C scFvC6.5-sTrail fusion gene and protein, and its preparation
1 ... 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 ... 3163